A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications
Abstract
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications.
Key facts
- NIH application ID
- 10671440
- Project number
- 75N93021C00034-P00005-9999-1
- Recipient
- INTRALYTIX, INC.
- Principal Investigator
- MEL RUZICKA
- Activity code
- N44
- Funding institute
- NIH
- Fiscal year
- 2022
- Award amount
- $1,498,045
- Award type
- —
- Project period
- 2021-08-16 → 2025-08-15